Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Lilly to Participate in Evercore ISI 3rd Annual HealthCONx Conference


INDIANAPOLIS, Nov. 24, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020. Michael Mason, Lilly senior vice president and president of Lilly Diabetes and Connected Care, will participate in a virtual fireside chat at 2:40 p.m., Eastern Time.  

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:   

Mark Taylor; [email protected]; (317) 276-5795 (Media)   


Kevin Hern; [email protected]; (317) 277-1838 (Investors)

 

Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)

SOURCE Eli Lilly and Company


These press releases may also interest you

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:52
Invest in Bogota ventures into Miami's thriving entrepreneurial scene for investment opportunities
In celebration of Miami Tech Month, the city of Miami is hosting a variety of events, welcoming venture capitalists, entrepreneurs, and technology innovators from around the globe. During this week, the city hosted Startup OLÉ, one of Europe's...

at 18:25
Skyhigh Security Named a Visionary in the 2024 Gartner® Magic Quadranttm for Security Service Edge
Skyhigh Security today announced it was named a Visionary in the 2024 Gartner® Magic Quadranttm for the second year in a row for its Security Service Edge (SSE) portfolio. The Magic Quadrant evaluates vendors based on their Ability to Execute and...

at 18:15
The UAE's Largest Higher Education Institution, Higher Colleges of Technology, Selects YuJa Video Platform to Serve More than 23,000 Students at 17 Campuses
After a rigorous RFP process, the system of the Higher Colleges of Technology (HCT) has selected the YuJa Enterprise Video Platform to serve more than 23,000 students and 2,000 staff at its 17 modern, technology-enhanced campuses in the United Arab...

at 17:46
PowerThru by CASETiFYtm Collection: New Wireless Car Charger, Fast Charger & 240W Cable
CASETiFY, the global tech accessory brand loved by millennials, Gen Z, and Hollywood celebrities, announces today its newest collection that caters to the diverse charging requirements of today's cutting-edge technology. With a mission to ensure that...

at 17:35
Tungray Technologies Inc Announces Pricing of Initial Public Offering
Tungray Technologies Inc ("Tungray" or the "Company" or "Tungray") , a provider of customized industrial manufacturing solutions to Original Equipment Manufacturers (OEMs) in the semiconductors, printers, electronics, and home appliances industries,...

More news about Science and technology...


News published on and distributed by: